Navigation Links
Jazz Pharmaceuticals Announces Third Quarter 2012 Results
Date:11/8/2012

justed information is included with this press release.

Revenues and Product SalesTotal revenues for the quarter ended September 30, 2012 were $175.5 million, including net sales, royalties and contract revenues, but excluding the $8.1 million of net sales attributable to the divested women's health business that were reported separately as discontinued operations.  

A significant increase in total net sales for the third quarter of 2012 over the prior year third quarter resulted from the addition of net sales from the expanded product portfolio acquired in the Azur Pharma and EUSA Pharma transactions, as well as continued growth in net sales of Xyrem® (sodium oxybate) oral solution.Net sales from continuing operations for the third quarter of 2012 included:

  • Xyrem:  Net sales of Xyrem increased by 64% to $102.6 million for the third quarter of 2012, compared to net sales of $62.5 million in the third quarter of 2011. During the third quarter of 2012, the average number of active Xyrem patients was approximately 10,200.
  • Erwinaze/Erwinase: Worldwide net sales of Erwinaze®/Erwinase® (asparaginase Erwinia chrysanthemi) were $31.7 million.  Erwinaze was approved by the U.S. FDA in November 2011.
  • Prialt:  Third quarter 2012 net sales of Prialt® (ziconotide) intrathecal infusion were $5.4 million, compared to $5.0 million in the prior year quarter on a pro forma basis.
  • Psychiatry Products:  Net sales of the company's psychiatry products, including once-daily Luvox CR® (fluvoxamine maleate), FazaClo® (clozapine, USP) HD and FazaClo LD, were $21.0 million for the third quarter of 2012.  Net sales of these products in the prior year quarter were $19.7 million on a pro forma basis.
  • Other:  Net sales of other products for the third
    '/>"/>

  • SOURCE Jazz Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

    Related medicine technology :

    1. Harwood Feffer LLP Announces Investigation of DUSA Pharmaceuticals, Inc.
    2. Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences
    3. Isis Pharmaceuticals To Present At The 2012 Credit Suisse Healthcare Conference
    4. Savient Pharmaceuticals Reports Third Quarter 2012 Financial Results
    5. Genoa Pharmaceuticals announces $1.2M Financing
    6. Inovio Pharmaceuticals Reports 2012 Third Quarter Financial Results
    7. Arisaph Pharmaceuticals Reports Positive Results From Two Safety Clinical Trials For Its Niacin Analog (ARI-3037MO)
    8. Oramed Pharmaceuticals to Present at the 12th Annual Diabetes Technology Society Meeting in Bethesda, MD, Nov 8-10, 2012
    9. Optimer Pharmaceuticals to Present at November 2012 Investor Conferences
    10. Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2012 Financial Results
    11. Isis Pharmaceuticals To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/29/2015)... 2015 Axxess , an industry leader ... software vendor accredited by the American Nursing Credentialing Center ... health agencies select the right revenue cycle management (RCM) ... their business. Research by American Health Information ... expect a decrease in productivity of 54.4 - 69 ...
    (Date:6/29/2015)... Md. , June 29, 2015 The ... New Jersey Board of Professional ... a provider of courses to professional engineers for continuing ... accreditation further demonstrates the value and quality of PDA,s ... . "Our lecture courses and hands-on professional training at ...
    (Date:6/29/2015)... SOUTH EASTON, Mass. , June 29, 2015 ... the "Company"), a leader in the development and ... sample preparation solutions to the worldwide life sciences ... of the Institute of Molecular Systems Biology, ETH ... the proteomic profiling and classification of prostate cancer ...
    Breaking Medicine Technology:Axxess Releases eGuide for Home Health Agencies, Revenue Cycle Management: What You Must Do Now - to Succeed! 2Better Classification of Prostate Cancer Tissue Biopsy Samples Enabled by Pressure BioSciences' PCT Platform 2Better Classification of Prostate Cancer Tissue Biopsy Samples Enabled by Pressure BioSciences' PCT Platform 3Better Classification of Prostate Cancer Tissue Biopsy Samples Enabled by Pressure BioSciences' PCT Platform 4
    ... , CARLSBAD, Calif., Dec. 21 Isis Pharmaceuticals, Inc. (Nasdaq: ... $10 million payment from OncoGenex Pharmaceuticals, Inc. (Nasdaq: ... to Teva Pharmaceutical Industries Ltd. ( TEVA). OGX-011 is ... has completed a successful Phase 2 program in patients with ...
    ... , , , STOCKHOLM, December ... raising 380 MSEK (approximately 36,MEUR). This will secure Karolinska Development,s ... "The significant interest in this share issue shows ... us to pursue our long term,investment strategy. I am also ...
    Cached Medicine Technology:Isis Pharmaceuticals to Receive $10 Million From OncoGenex' License of OGX-011 to Teva 2Isis Pharmaceuticals to Receive $10 Million From OncoGenex' License of OGX-011 to Teva 3Karolinska Development New Share Issue Completed - Raising 380 MSEK (36 MEUR) 2
    (Date:6/30/2015)... ... 30, 2015 , ... New Xarelto lawsuit claims proposed for ... new forms, according to attorneys handling Xarelto lawsuits included in the ... “provide guidance” for plaintiffs’ attorneys in filing new claims, according to court documents. ...
    (Date:6/30/2015)... ... June 30, 2015 , ... AvePoint, the established ... of three new apps – AvePoint Watermark, AvePoint MyWorld, and ... of these apps, workers can better streamline everyday business operations and take advantage of ...
    (Date:6/30/2015)... ... June 30, 2015 , ... The American ... 2015 at Disney’s Coronado Springs Resort in Lake Buena Vista, Florida, and will ... this premiere event for psychiatric-mental health nursing draws more than 1,500 health care ...
    (Date:6/30/2015)... ... June 30, 2015 , ... This Fourth of July, ... the Peacock Alley story including hard work, tenacity, perseverance, commitment to quality, honesty and ... , Born of Mary Ella Gabler's simple love of quilts, Peacock Alley was ...
    (Date:6/29/2015)... ... June 30, 2015 , ... Sublime Beauty NATURALS® introduces its ... The oil, ideal for natural skincare and even culinary uses, was especially designed ... something most people desire, and Oil Pulling can accomplish this. Oil Pulling is an ...
    Breaking Medicine News(10 mins):Health News:Xarelto Lawsuit News: New Xarelto Lawsuit Filings to Be Expedited 2Health News:Xarelto Lawsuit News: New Xarelto Lawsuit Filings to Be Expedited 3Health News:AvePoint Enhances Workforce Productivity and Document Protection on Microsoft Office 365 with the Release of Three New Apps 2Health News:AvePoint Enhances Workforce Productivity and Document Protection on Microsoft Office 365 with the Release of Three New Apps 3Health News:AvePoint Enhances Workforce Productivity and Document Protection on Microsoft Office 365 with the Release of Three New Apps 4Health News:American Psychiatric Nurses Association 29th Annual Conference: Continuing Education and Collaboration in Psychiatric-Mental Health and Nursing 2Health News:American Psychiatric Nurses Association 29th Annual Conference: Continuing Education and Collaboration in Psychiatric-Mental Health and Nursing 3Health News:Luxury Linen Purveyor Peacock Alley Celebrates the Fourth of July 2Health News:New Product: Transform Wellness and Oral Health With This Ancient Ayurvedic Secret and Organic Product from Sublime Beauty NATURALS® 2
    ... Hillenbrand,Industries, Inc. (NYSE: HB ) today announced ... share. This dividend was declared by Hillenbrand,s,Board of ... to shareholders of,record as of September 14, 2007. ... is organized into two operating companies,serving the health ...
    ... Fair Election Agreement Would Establish Rules for Union Process, ... Medical Centers delivered a message to CEO Tim Joslin ... hospital,facilities are putting the quality of treatment offered there ... negotiate a free and fair election,agreement with employees who ...
    ... where small changes make a huge impact, PHILADELPHIA, ... we celebrate the end of Healthy Steps, a six-week ... Housing,Authority, and Philadelphia Safe and Sound on Friday, September ... Center, 2500 Jackson Street in,South Philadelphia., The Urban ...
    ... million from the Centers for Disease Control and Prevention ... HIV/AIDS in eight countries that lack the large-scale public ... million of the grant will support the efforts of ... Health of Ethiopia and rural Jimma University, to ...
    ... CHAPEL HILL, N.C., Sept. 7 Pharmaceutical companies,face ... product research,sales and marketing forces, and quality production ... the industry. The case studies in the,Multi-Year Compendium ... more. They were presented by industry leaders at ...
    ... Sept. 7 With safety issues making,headlines, ... rugged,regulatory landscape. Organizations are relying on their ... affect production. Proper,staffing of quality roles is ... and a study by pharmaceutical benchmarking leader ...
    Cached Medicine News:Health News:Hospital Workers: Management Threatens Patient Care 2Health News:On September 7th Local Organizations Partner to Celebrate 'Healthy Steps' 2Health News:Tulane University to receive $14M for international HIV/AIDS program 2Health News:Multi-Year Compendium of Pharmaceutical Case Studies Available from Best Practices, LLC 2Health News:Pharmaceutical Manufacturing Quality: Optimizing Your Internal Process for FDA Compliance 2
    For regulating sample flow rate when using the QIAvac 24 Plus;...
    For processing mini spin columns on QIAvac 24;...
    DNA/RNA preparation in 8-multi channels...
    ... Filter Units,Filter units with hydrophobic PTFE ... membrane are ideal for the sterilizing ... sterile containers, and for sterilizing or ... mm Millex filter units are available ...
    Medicine Products: